Syndax Pharmaceuticals (SNDX) Financials: Revenue & Earnings
SNDX$13.89+0.20 +1.46%
$1.24B
Market Cap
-5.32
P/E
39.56
Forward P/E
—
Score
Syndax Pharmaceuticals (SNDX) Financials: Revenue & Earnings
SNDX price $13.89 +0.20 +1.46%
- Ticker
- SNDX
- Price
- $13.89
- Change
- +0.20 +1.46%
- Market cap ?
- $1.24B
- P/E ?
- -5.32
- Forward P/E ?
- 39.56
- Dividend yield ?
- 0.00%
- Beta ?
- 0.37
- Sector
- Healthcare
- Industry
- Biotechnology
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1220000 | 2108000 | 1517000 | 1517000 | 1517000 | 139709000 | 0 | 0 | 23680000 | 172352000 |
Syndax Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm focused on developing innovative therapies for cancer. Among its leading investigational products are SNDX-5613, currently undergoing Phase 1/2 clinical assessment, which targets the Menin-mixed lineage leukemia 1 protein interaction for treating MLL-rearranged (MLLr) and nucleophosmin 1 mutant acute myeloid leukemia (NPM1c AML)…
Fair value
SNDX fair value $15.93. Price $13.89. Price is 13% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 39.15M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 89.30M. Net debt 211.55M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-02 | — | -0.52 | — | 81.92M |
| 2026-08-04 | -0.55 | -0.45 | 72.79M | 79.37M |
| 2026-04-30 | -0.48 | -0.59 | 64.86M | 69.76M |
| 2026-02-26 | -0.78 | -0.58 | 68.73M | 64.30M |
| 2025-11-03 | -0.70 | -0.74 | 45.87M | 63.34M |
| 2025-08-04 | -0.83 | -1.00 | 37.96M | 45.65M |
| 2025-05-05 | -0.98 | -1.04 | 20.04M | 18.55M |
| 2025-03-03 | -1.10 | -1.08 | 7.68M | 12.79M |
| 2024-11-05 | -0.98 | -1.13 | 12.50M | 115.23M |
| 2024-08-01 | -0.80 | -0.91 | 3.50M | — |
| 2024-05-08 | -0.85 | -0.96 | — | — |
| 2024-02-27 | -1.00 | -0.99 | 536.00K | — |
| 2023-11-02 | -0.73 | -0.80 | — | — |
| 2023-08-03 | -0.64 | -0.73 | — | — |
| 2023-05-08 | -0.59 | -0.61 | — | 430.00K |
| 2023-02-28 | -0.62 | -0.64 | — | 1.33M |
| 2022-11-03 | -0.58 | -0.65 | — | 750.00K |
| 2022-08-08 | -0.62 | -0.65 | — | 1.38M |
| 2022-05-09 | -0.63 | -0.63 | — | 2.56M |
| 2022-03-01 | 1.81 | 0.28 | 126.58M | 6.29M |
| 2021-11-15 | -0.40 | -0.64 | 12.38M | 11.98M |
| 2021-08-09 | -0.44 | -0.74 | 379.00K | 379.00K |
| 2021-05-11 | -0.54 | -0.64 | 379.00K | 220.00K |
| 2021-03-08 | -0.44 | -0.43 | 380.00K | 240.00K |
| 2020-11-02 | -0.46 | -0.42 | 379.00K | 363.48K |
| 2020-08-06 | -0.42 | -0.47 | 379.00K | 406.07K |
| 2020-05-07 | -0.56 | -0.51 | 379.00K | 345.16K |
| 2020-03-03 | -0.44 | -0.46 | 380.00K | 361.77K |
| 2019-11-07 | -0.41 | -0.48 | 379.00K | 434.46K |
| 2019-08-07 | -0.47 | -0.44 | 379.00K | 346.74K |
| 2019-05-06 | -0.53 | -0.56 | 379.00K | 400.45K |
| 2019-03-07 | -0.70 | -0.68 | 380.00K | 362.76K |
| 2018-11-05 | -0.68 | -0.76 | 379.00K | 423.59K |
| 2018-08-07 | -0.74 | -0.91 | 379.00K | 445.58K |
| 2018-05-08 | -0.79 | -1.02 | 379.00K | 460.56K |
| 2018-03-05 | -0.80 | -0.85 | 1.19M | 1.16M |
| 2017-11-07 | -0.68 | -0.80 | 305.00K | 358.82K |
| 2017-08-10 | -0.70 | -0.79 | 305.00K | 361.64K |
| 2017-05-08 | -0.71 | -0.74 | 305.00K | 300.70K |
| 2017-03-02 | -0.59 | -0.77 | 305.00K | 377.37K |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-07-08 | Metzger Michael A | Buy | 32.38K | $6.38 | 206.55K |
| 2026-07-08 | Metzger Michael A | Sell | 32.38K | $24.24 | 784.78K |
| 2026-07-08 | Metzger Michael A | Buy | 32.38K | $6.38 | 206.55K |
| 2026-06-12 | Botwood Nicholas A.J. | Buy | 31.23K | $13.82 | 431.67K |
| 2026-06-12 | Botwood Nicholas A.J. | Sell | 31.23K | $18.14 | 566.60K |
| 2026-06-12 | Botwood Nicholas A.J. | Buy | 31.23K | $13.82 | 431.67K |
| 2026-06-11 | Botwood Nicholas A.J. | Buy | 22.52K | $13.82 | 311.16K |
| 2026-06-11 | Botwood Nicholas A.J. | Sell | 34.28K | $18.00 | 617.04K |
| 2026-06-01 | Goldan Keith A. | Sell | 1.18K | $18.99 | 22.35K |
| 2026-06-01 | Metzger Michael A | Sell | 6.85K | $18.99 | 130.02K |
| 2026-02-09 | Metzger Michael A | Sell | 17.16K | $21.03 | 360.82K |
| 2026-02-09 | Goldan Keith A. | Sell | 3.41K | $21.03 | 71.71K |
| 2026-02-06 | Metzger Michael A | Sell | 7.41K | $20.62 | 152.84K |
| 2026-02-06 | Goldan Keith A. | Sell | 2.08K | $20.62 | 42.93K |
| 2026-02-04 | Metzger Michael A | Buy | 144.60K | — | — |
| 2026-02-04 | Metzger Michael A | Buy | 440.00K | $20.43 | 8.99M |
| 2026-02-04 | Metzger Michael A | Buy | 73.00K | — | — |
| 2026-02-04 | Goldan Keith A. | Buy | 30.75K | — | — |
| 2026-02-04 | Goldan Keith A. | Buy | 118.00K | $20.43 | 2.41M |
| 2026-02-04 | Goldan Keith A. | Buy | 21.50K | — | — |
| 2026-02-04 | Jarrett Jennifer | Buy | 24.00K | — | — |
| 2026-02-04 | Huber Martin H. Jr. | Buy | 24.00K | — | — |
| 2026-02-04 | Botwood Nicholas A.J. | Buy | 144.70K | $20.43 | 2.96M |
| 2026-02-04 | Botwood Nicholas A.J. | Buy | 36.00K | — | — |
| 2026-02-04 | Botwood Nicholas A.J. | Buy | 24.00K | — | — |
| 2026-02-04 | Podlesak Dennis | Buy | 48.00K | — | — |
| 2026-02-04 | Rizo Aleksandra | Buy | 24.00K | — | — |
| 2026-02-04 | Katkin Keith | Buy | 24.00K | — | — |
| 2026-02-04 | Legault Pierre | Buy | 24.00K | — | — |
| 2026-01-30 | Goldan Keith A. | Buy | 1.22K | $8.48 | 10.34K |
| 2025-12-01 | Goldan Keith A. | Sell | 1.22K | — | — |
| 2025-09-08 | Metzger Michael A | Buy | 157.31K | $10.90 | 1.71M |
| 2025-09-08 | Metzger Michael A | Sell | 157.31K | $16.41 | 2.58M |
| 2025-09-08 | Metzger Michael A | Buy | 157.31K | $10.90 | 1.71M |
| 2025-08-18 | Podlesak Dennis | Buy | 19.20K | $7.20 | 138.24K |
| 2025-08-18 | Podlesak Dennis | Sell | 19.20K | $15.84 | 304.17K |
| 2025-08-18 | Podlesak Dennis | Sell | 19.20K | $7.20 | 138.24K |
| 2025-08-15 | Podlesak Dennis | Sell | 19.20K | $15.54 | 298.41K |
| 2025-08-14 | Podlesak Dennis | Sell | 19.20K | $14.19 | 272.52K |
| 2025-07-31 | Goldan Keith A. | Buy | 1.23K | $8.43 | 10.34K |
| 2025-07-16 | Goldan Keith A. | Sell | 1.30K | $9.29 | 12.03K |
| 2025-07-16 | Metzger Michael A | Sell | 7.53K | $9.29 | 69.95K |
| 2025-05-19 | Goldan Keith A. | Buy | 3.00K | — | — |
| 2025-05-19 | Huber Martin H. Jr. | Buy | 5.00K | $8.99 | 44.95K |
| 2025-05-19 | Katkin Keith | Buy | 10.00K | $9.11 | 91.12K |
| 2025-05-16 | Botwood Nicholas A.J. | Buy | 11.77K | $8.99 | 105.83K |
| 2025-05-12 | Botwood Nicholas A.J. | Other | 0 | — | — |
| 2025-05-12 | Botwood Nicholas A.J. | Other | 215.00K | $13.82 | 2.97M |
| 2025-03-14 | Metzger Michael A | Buy | 6.07K | $7.20 | 43.73K |
| 2025-03-14 | Metzger Michael A | Buy | 6.07K | $7.20 | 43.73K |
| 2025-03-04 | Metzger Michael A | Buy | 7.81K | $7.20 | 56.26K |
| 2025-03-04 | Metzger Michael A | Sell | 7.81K | $15.05 | 117.56K |
| 2025-03-04 | Metzger Michael A | Buy | 7.81K | $7.20 | 56.26K |
| 2025-02-10 | Goldan Keith A. | Sell | 3.78K | $15.50 | 58.56K |
| 2025-02-10 | Metzger Michael A | Sell | 13.29K | $15.50 | 206.02K |
| 2025-02-10 | Gallagher Neil | Sell | 4.62K | $15.50 | 71.60K |
| 2025-02-05 | Gallagher Neil | Buy | 110.50K | $14.65 | 1.62M |
| 2025-02-05 | Gallagher Neil | Buy | 23.40K | — | — |
| 2025-02-05 | Gallagher Neil | Buy | 18.50K | — | — |
| 2025-02-05 | Goldan Keith A. | Buy | 110.50K | $14.65 | 1.62M |
| 2025-02-05 | Goldan Keith A. | Buy | 23.40K | — | — |
| 2025-02-05 | Goldan Keith A. | Buy | 18.50K | — | — |
| 2025-02-05 | Metzger Michael A | Buy | 364.00K | $14.65 | 5.33M |
| 2025-02-05 | Metzger Michael A | Buy | 89.00K | — | — |
| 2025-02-05 | Metzger Michael A | Buy | 60.50K | — | — |
| 2025-02-05 | Podlesak Dennis | Buy | 50.00K | — | — |
| 2025-02-05 | Rizo Aleksandra | Buy | 25.00K | — | — |
| 2025-02-05 | Meury William | Buy | 25.00K | — | — |
| 2025-02-05 | Katkin Keith | Buy | 25.00K | — | — |
| 2025-02-05 | Jarrett Jennifer | Buy | 25.00K | — | — |
| 2025-02-05 | Huber Martin H. Jr. | Buy | 25.00K | — | — |
| 2025-02-05 | Legault Pierre | Buy | 25.00K | — | — |
| 2024-06-14 | Goldan Keith A. | Buy | 1.25K | $20.03 | 25.04K |
| 2024-05-15 | Rizo Aleksandra | Buy | 35.00K | $21.94 | 767.90K |
| 2024-05-15 | Rizo Aleksandra | Other | 0 | — | — |
| 2024-02-07 | Metzger Michael A | Buy | 214.50K | $22.28 | 4.78M |
| 2024-02-07 | Metzger Michael A | Buy | 39.00K | — | — |
| 2024-02-07 | Metzger Michael A | Buy | 107.25K | — | — |
| 2024-02-07 | Goldan Keith A. | Buy | 70.00K | $22.28 | 1.56M |
| 2024-02-07 | Goldan Keith A. | Buy | 11.70K | — | — |
| 2024-02-07 | Goldan Keith A. | Buy | 35.00K | — | — |
| 2024-02-07 | Gallagher Neil | Buy | 69.38K | $22.28 | 1.55M |
| 2024-02-07 | Gallagher Neil | Buy | 13.12K | — | — |
| 2024-02-07 | Gallagher Neil | Buy | 34.69K | — | — |
| 2024-02-07 | Huber Martin H. Jr. | Buy | 17.00K | — | — |
| 2024-02-07 | Jarrett Jennifer | Buy | 17.00K | — | — |
| 2024-02-07 | Katkin Keith | Buy | 17.00K | — | — |
| 2024-02-07 | Meury William | Buy | 17.00K | — | — |
| 2024-02-07 | Morrison Briggs | Buy | 17.00K | — | — |
| 2024-02-07 | Podlesak Dennis | Buy | 34.00K | — | — |
| 2024-02-07 | Legault Pierre | Buy | 17.00K | — | — |
| 2024-01-31 | Goldan Keith A. | Buy | 1.18K | $17.42 | 20.61K |
| 2023-08-09 | Morrison Briggs | Buy | 52.85K | $8.77 | 463.54K |
| 2023-08-09 | Morrison Briggs | Sell | 52.85K | $18.27 | 965.40K |
| 2023-08-09 | Morrison Briggs | Sell | 52.85K | $8.77 | 463.54K |
| 2023-08-02 | Meury William | Buy | 35.00K | $7.11 | 248.85K |
| 2023-08-02 | Meury William | Buy | 24.00K | $9.47 | 227.28K |
| 2023-08-02 | Meury William | Buy | 24.00K | $7.88 | 189.12K |
| 2023-08-02 | Meury William | Sell | 35.00K | $20.46 | 715.95K |
| 2023-08-02 | Meury William | Sell | 24.00K | $20.45 | 490.91K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 254, holders -7 vs prior quarter. Ownership 122.39%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 9.02M | 765.58K | +9.27% | 197.18M |
| KYNAM CAPITAL MANAGEMENT, LP | 8.05M | 0 | 0.00% | 175.99M |
| GOLDMAN SACHS GROUP INC | 5.86M | 864.48K | +17.30% | 128.13M |
| STATE STREET CORP | 5.66M | 1.23M | +27.73% | 123.69M |
| BANK OF AMERICA CORP /DE/ | 4.05M | -204.74K | -4.82% | 88.43M |
| VANGUARD CAPITAL MANAGEMENT LLC | 3.93M | 105.31K | +2.76% | 85.86M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | 3.78M | 0 | 0.00% | 82.63M |
| EVERSEPT PARTNERS, LP | 2.80M | -87.41K | -3.03% | 61.17M |
| GEODE CAPITAL MANAGEMENT, LLC | 2.58M | 427.08K | +19.80% | 56.50M |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 2.56M | 209.99K | +8.92% | 56.06M |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 2.50M | 0 | 0.00% | 54.65M |
| FRANKLIN TEMPLETON INC | 2.29M | 136.42K | +6.34% | 49.98M |
| MILLENNIUM MANAGEMENT LLC | 2.05M | 1.85M | +929.43% | 44.90M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 1.92M | 184.66K | +10.63% | 42.01M |
| UBS GROUP AG | 1.89M | 740.09K | +64.15% | 41.40M |
| ELMIND CAPITAL, LP | 1.85M | 0 | 0.00% | 40.55M |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 1.79M | 57.63K | +3.33% | 39.13M |
| CANDRIAM S.C.A. | 1.70M | 770.71K | +83.29% | 37.04M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 1.63M | -98.87K | -5.73% | 35.59M |
| TWO SIGMA INVESTMENTS, LP | 1.58M | -1.47K | -0.09% | 34.50M |
| ORBIMED ADVISORS LLC | 1.54M | 579.70K | +60.24% | 33.71M |
| NUVEEN, LLC | 1.36M | -130.07K | -8.70% | 29.83M |
| MPM BIOIMPACT LLC | 1.33M | -7.21K | -0.54% | 29.15M |
| AISLING CAPITAL MANAGEMENT LP | 1.32M | 0 | 0.00% | 28.79M |
| WOODLINE PARTNERS LP | 1.25M | 0 | 0.00% | 27.34M |
Earnings and financials
Syndax Pharmaceuticals, Inc. (SNDX) trades at $13.89, with a market cap of $1.24B and a trailing P/E of -5.32. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 1220000 | 2108000 | 1517000 | 1517000 | 1517000 | 139709000 | 0 | 0 | 23680000 | 172352000 |
Insights · Dividends · Forecast · Financials · Learn